These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35804208)

  • 1. Decreased GM3 correlates with proteinuria in minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Naito S; Kawashima N; Ishii D; Fujita T; Iwamura M; Takeuchi Y
    Clin Exp Nephrol; 2022 Nov; 26(11):1078-1085. PubMed ID: 35804208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
    Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular Density and Volume in Renal Biopsy Specimens of Children with Proteinuria Relative to Preterm Birth and Gestational Age.
    Koike K; Ikezumi Y; Tsuboi N; Kanzaki G; Haruhara K; Okabayashi Y; Sasaki T; Ogura M; Saitoh A; Yokoo T
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):585-590. PubMed ID: 28336816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis.
    Deegens JK; Dijkman HB; Borm GF; Steenbergen EJ; van den Berg JG; Weening JJ; Wetzels JF
    Kidney Int; 2008 Dec; 74(12):1568-76. PubMed ID: 18813290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
    Agrawal V; Prasad N; Jain M; Pandey R
    Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Cho MH; Hong EH; Lee TH; Ko CW
    Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.
    Taneda S; Honda K; Ohno M; Uchida K; Nitta K; Oda H
    Virchows Arch; 2015 Oct; 467(4):449-58. PubMed ID: 26266776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Kitano Y; Yoshikawa N; Nakamura H
    Clin Nephrol; 1993 Oct; 40(4):199-204. PubMed ID: 8261675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte mRNA in the urinary sediment of minimal change nephropathy and focal segmental glomerulosclerosis.
    Szeto CC; Wang G; Chow KM; Lai FM; Ma TK; Kwan BC; Luk CC; Li PK
    Clin Nephrol; 2015 Oct; 84(4):198-205. PubMed ID: 26308082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two different pathways of glomerular enlargement in adults with focal and segmental glomerulosclerosis: a morphometric study.
    Matsumae T; Fukuzaki M; Takebayashi S; Naito S
    Am J Nephrol; 1998; 18(1):21-7. PubMed ID: 9481435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible glomerular hypertrophy in adult patients with primary focal segmental glomerulosclerosis.
    Nishimoto K; Shiiki H; Nishino T; Uyama H; Iwano M; Dohi K
    J Am Soc Nephrol; 1997 Nov; 8(11):1668-78. PubMed ID: 9355069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Anti-Nephrin Antibody Mediated Podocyte Injury Model Using a C57BL/6 Mouse Strain.
    Takeuchi K; Naito S; Kawashima N; Ishigaki N; Sano T; Kamata K; Takeuchi Y
    Nephron; 2018; 138(1):71-87. PubMed ID: 28965116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
    Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
    Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic Analysis of Urinary Podocytes in Focal Segmental Glomerulosclerosis.
    Shirai Y; Miura K; Yokoyama T; Horita S; Nakayama H; Seino H; Ando T; Shiratori A; Yabuuchi T; Kaneko N; Ishiwa S; Ishizuka K; Hara M; Hattori M
    Kidney360; 2021 Mar; 2(3):477-486. PubMed ID: 35369007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
    Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome.
    Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Ebihara I; Koide H
    Am J Nephrol; 2000; 20(3):175-9. PubMed ID: 10878397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neph1 is reduced in primary focal segmental glomerulosclerosis, minimal change nephrotic syndrome, and corresponding experimental animal models of adriamycin-induced nephropathy and puromycin aminonucleoside nephrosis.
    Hulkko J; Patrakka J; Lal M; Tryggvason K; Hultenby K; Wernerson A
    Nephron Extra; 2014 Sep; 4(3):146-54. PubMed ID: 25404935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nonspecificity of focal segmental glomerulosclerosis. The defining characteristics of primary focal glomerulosclerosis, mesangial proliferation, and minimal change.
    McAdams AJ; Valentini RP; Welch TR
    Medicine (Baltimore); 1997 Jan; 76(1):42-52. PubMed ID: 9064487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.